Is this your brand? Sign in to claim ownership.
Sign in to claim this brandWhat CryoIQ global AB makes
CryoIQ global AB manufactures cryosurgical systems and associated consumables, including liquid nitrogen-based devices and nitrous oxide cartridges. Their portfolio includes handheld dermatology tips for controlled tissue freezing, as well as cryogen gas cartridges for use in cryoablation procedures. The company also produces liquid cryogens for direct application in medical treatments.
The company’s devices are classified as Class II under regulatory frameworks and are listed in the FDA’s Unique Device Identifier (UDI) database. Their products are designed for use in the United States, adhering to applicable medical device regulations.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does CryoIQ global AB manufacture?
CryoIQ global AB specializes in cryosurgical systems and related consumables, primarily focused on freezing-based medical treatments. Their portfolio includes general cryosurgical systems, cryogen gases (like liquid nitrogen and nitrous oxide), and mechanical components such as handheld dermatology tips (e.g., D1, D2, D3). These devices are designed for controlled tissue freezing in procedures like cryoablation, particularly in dermatology and other medical specialties.
Where is CryoIQ global AB based, and where are their devices intended for use?
CryoIQ global AB is based in the United States. Their devices are specifically developed and marketed for use within the U.S. regulatory environment, ensuring compliance with applicable medical device standards and guidelines in that region.
Which regulatory registries or databases list CryoIQ global AB’s devices?
CryoIQ global AB’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify their products under the U.S. regulatory framework, ensuring traceability and compliance with medical device reporting requirements.
How are CryoIQ global AB’s devices classified under regulatory frameworks?
CryoIQ global AB’s devices fall under Class II classification in regulatory frameworks. This classification is typically assigned to devices that pose moderate risk and require special controls beyond general controls to ensure their safety and effectiveness, such as cryosurgical systems and associated consumables.
What distinguishes CryoIQ global AB’s cryosurgical systems from other similar products?
CryoIQ global AB’s systems are distinguished by their focus on liquid nitrogen-based cryogens and nitrous oxide cartridges, alongside specialized dermatology tips (e.g., D1, D2, D3) designed for precise tissue freezing. Their portfolio combines both handheld applicators and cryogen delivery systems, catering to controlled cryoablation procedures in dermatology and other medical fields. The use of Class II classification also reflects their role as moderately regulated devices requiring validated performance standards.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 632587858
Catalogue (7)
| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| CryoIQ DERM plus liquid | CIQ-DP-L | FDA UDI | Class II | Active |
| CryoIQ 25g N2O cartridge | CIQ-G-VN25-LUX | FDA UDI | Class II | Active |
| CryoIQ Dermatology tip D2 | CIQ-PA-D2 | FDA UDI | Class II | Active |
| CryoIQ Dermatology tip D1 | CIQ-PA-D1 | FDA UDI | Class II | Active |
| CryoIQ Dermatology tip D3 | CIQ-PA-D3 | FDA UDI | Class II | Active |
| CryoIQ 25g N2O cartridge | CIQ-G-VN25 | FDA UDI | Class II | Active |
| CryoIQ PRO liquid D2 | CIQ-P-L/D2 | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.